Company Profile
Efung Capital is one of the earliest private equity investment institutions developing venture capital businesses specializing in healthcare industry investment. Efung is composed of a high-caliber management team and an experienced investment team consisting of MDs/PhDs who graduated from top universities all over the world. For years, Efung Capital has been consistently pursuing the long-term value of biopharmaceuticals and high-end medical devices, including over 80 investment companies globally, such as Chipscreen Bioscience, Frontier Biotech, Ascentage Pharma, Lifotronic Technology, OBiO Technology , ASIERIS MediTech, 3D Medicines and Harbour BioMed et al. We have demonstrated a solid track record and achieved strong revenue and earnings growth. Efung capital was recognized as“Zero2IPO Group2022 Best Healthcare Investment Institution TOP30, Zero2IPO Group 2022 Top 100 China Venture Capital Firms , China Venture2022 Top30 China Venture Capital Firms ,China Venture 2020 Best Healthcare Investment Institution TOP30,China Venture 2019 Best Exit Cases TOP10and The Most Dynamic Pharmaceutical VC Institutions in China.”. Additionally, it has been elected“Shenzhen TOP10 VC Institutions”for several consecutive years and once was theme covered by Nature magazine.
                Development Path                               
<
  • 2001
    2001
    The founder of Efung Captital invested Mindray Medical
  • 2007
    2007
    Efung Captital was officially established and had formed a professional investment team.
  • 2012
    2012
    Transformed into a life-science focused venture capital firm.
  • 2014
    2014
    Raised and invested the first fund.
  • 2015
    2015
    Started the research and analysis of oversea pharmaceutical and healthcare industry.
  • 2017
    2017
    Start laying out overseas high-quality projects
  • 2019
    2019
    The invested projects are listed one after another
  • 2021
    2021
    Efung JunMa was established
>
Advantages
——
——
Professional
——
——
Focused
——
——
Resourceful
——
——
Strategic
——
——
Collaborative
——
——
Prudent
Address: 505 China Resources Building, 2666 Keyuan South Road, Nanshan District, Shenzhen
TEL:0755-8831-6141
E-mail:info@efungcapital.com
Copyright ©2018 - 2021 Shenzhen Efung Investment Management Co. Ltd.
Rhino Cloud provides enterprise cloud services
犀牛云提供云计算服务
进入手机网站